|
Status |
Public on Jan 19, 2014 |
Title |
Overcoming chemoresistance in B lymphoma cells: elucidating the role of NF-kB in caspase-independent apoptosis by transcriptomic assessment. |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Although therapy responsiveness to therapy in Burkitt lymphoma (BL) is high, relapsed disease and and chemoresistance remain a clinical challenge, and complete mechanisms underlying BL chemoresistance and how it can be circumvented is yet to be fully elucidated. In this study we present data showing that chymotrypsin-like serine proteases inhibitor Nα-tosyl-L-phenylalanine chloromethylketone (TPCK) and specific NF-κB inhibitor Bay-11 7082 can induce caspase-independent apoptosis in chemoresistant BL cells. We also demonstrate that both TPCK and Bay-11 7082-treatment leads to decreased NF-κB nuclear activity and that this is associated with sensitization of chemoresistant Burkitt lymphoma cells. Furthermore we investigated global transcriptional changes induced by Bay-11 7082 and TPCK in the DG-75 and Raji cell lines, respectively, by microarray analysis using Illumina BeadChips. TPCK-treatment of Raji and DG-75 cells resulted in 59 and 21 differently expressed genes, respectively, while Bay-11-treated Raji and DG-75 cells displayed 1403 and 8 differently expressed genes, respectively. Gene Ontology (GO) categorization confirmed enrichment of multiple GOs in Bay 11-treated Raji and DG-75 cells. Fifty percent of the 61 categories in Raji cells were categories sorting under Biological Processes and represented mostly increased gene expression. In DG-75 cells Bay-11 7082 induced significant gene ontology enrichment in only two categories, where the increased/decreased ratio was 1:1. Further unsupervised and supervised bioinformatics processing by Ingenuity Pathway Analysis indicated significant networks in response to TPCK and Bay 11 respectively, including association to NF-κB. Bay-11 7082 demonstrated deregulated NF-κB related members of receptor mediated cell death signaling, i.e TRAF2 and TRADD, as well as deregulated members of the NF-κB signaling pathway from the cytoplasmic compartment, i.e RELB, in Raji cells. Comparably NF-κB network analysis of Raji- and DG-75 cells treated with Bay-11 7082 and Raji cells treated with TPCK demonstrated deregulation of NF-κB target genes CD69 and IL8. These data indicates that NF-kB may play a role in overcoming chemoresistance in BL cells with defective classical apoptosis signaling.
|
|
|
Overall design |
NF-κB network analysis of Raji- and DG-75 cells treated with Bay-11 7082 and Raji cells treated with TPCK
|
|
|
Contributor(s) |
Ottosson-Wadlund A, Jitkaew S, Johansson I, Fucharoen S, Hedenfalk I, Fadeel B |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Aug 08, 2011 |
Last update date |
Aug 16, 2018 |
Contact name |
Ida Johansson |
E-mail(s) |
ida.johansson@med.lu.se
|
Organization name |
Lund University
|
Department |
Oncology
|
Street address |
Department of Oncology Clinical Sciences Lund University BMC C13
|
City |
Lund |
ZIP/Postal code |
SE-22184 |
Country |
Sweden |
|
|
Platforms (1) |
GPL6947 |
Illumina HumanHT-12 V3.0 expression beadchip |
|
Samples (18)
|
GSM774710 |
Burkitt lymphoma cell line Raji 1 h rep1 |
GSM774711 |
Burkitt lymphoma cell line Raji 1 h rep2 |
GSM774712 |
Burkitt lymphoma cell line Raji 1 h rep3 |
GSM774713 |
Burkitt lymphoma cell line 75 µM Raji TPCK 1 h rep1 |
GSM774714 |
Burkitt lymphoma cell line 75 µM Raji TPCK 1 h rep2 |
GSM774715 |
Burkitt lymphoma cell line 75 µM Raji TPCK 1 h rep3 |
GSM774716 |
Burkitt lymphoma cell line 50 µM Raji Bay-11 1 h rep1 |
GSM774717 |
Burkitt lymphoma cell line 50 µM Raji Bay-11 1 h rep2 |
GSM774718 |
Burkitt lymphoma cell line 50 µM Raji Bay-11 1 h rep3 |
GSM774719 |
Burkitt lymphoma cell line 50 µM DG75 Bay-11 1 h rep1 |
GSM774720 |
Burkitt lymphoma cell line 50 µM DG75 Bay-11 1 h rep2 |
GSM774721 |
Burkitt lymphoma cell line 50 µM DG75 Bay-11 1 h rep3 |
GSM774722 |
Burkitt lymphoma cell line DG75 1 h rep1 |
GSM774723 |
Burkitt lymphoma cell line DG75 1 h rep2 |
GSM774724 |
Burkitt lymphoma cell line DG75 1 h rep3 |
GSM774725 |
Burkitt lymphoma cell line 75 µM DG75 TPCK 1 h rep1 |
GSM774726 |
Burkitt lymphoma cell line 75 µM DG75 TPCK 1 h rep2 |
GSM774727 |
Burkitt lymphoma cell line 75 µM DG75 TPCK 1 h rep3 |
|
Relations |
BioProject |
PRJNA144827 |